In addition, we found the E-cadherin expression was upregulated, while N-cadherin expression was downregulated under OMT + DOX (Figures 4B,E–F,H–I), revealing that combination use could suppress CRC cell epithelial–mesenchymal transition (EMT) characteristics. The gene discussed is CDH2; the disease is colorectal carcinoma.